Colin R. James

895 total citations
9 papers, 574 citations indexed

About

Colin R. James is a scholar working on Genetics, Cancer Research and Molecular Biology. According to data from OpenAlex, Colin R. James has authored 9 papers receiving a total of 574 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 4 papers in Cancer Research and 3 papers in Molecular Biology. Recurrent topics in Colin R. James's work include BRCA gene mutations in cancer (5 papers), Breast Cancer Treatment Studies (2 papers) and HER2/EGFR in Cancer Research (2 papers). Colin R. James is often cited by papers focused on BRCA gene mutations in cancer (5 papers), Breast Cancer Treatment Studies (2 papers) and HER2/EGFR in Cancer Research (2 papers). Colin R. James collaborates with scholars based in United Kingdom, Canada and Germany. Colin R. James's co-authors include Jennifer E. Quinn, Paul B. Mullan, Patrick G. Johnston, D. Paul Harkin, Gail E. Stewart, Richard D. Kennedy, D. Paul Harkin, Jude M. Mulligan, R. H. Wilson and Judith Carser and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Nature Reviews Clinical Oncology.

In The Last Decade

Colin R. James

9 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Colin R. James United Kingdom 8 314 259 189 177 112 9 574
Philip C. Schouten Netherlands 12 325 1.0× 326 1.3× 243 1.3× 169 1.0× 94 0.8× 26 649
Kristen L. Lozada United States 9 441 1.4× 212 0.8× 127 0.7× 174 1.0× 68 0.6× 9 669
Eniko Papp United States 5 229 0.7× 144 0.6× 255 1.3× 116 0.7× 60 0.5× 11 479
Åke Borg Sweden 13 446 1.4× 231 0.9× 234 1.2× 329 1.9× 86 0.8× 15 823
Grazia Palomba Italy 17 347 1.1× 229 0.9× 248 1.3× 167 0.9× 38 0.3× 41 660
J. E. Quinn United Kingdom 6 476 1.5× 380 1.5× 259 1.4× 292 1.6× 51 0.5× 11 776
Yong Xian United States 9 473 1.5× 210 0.8× 76 0.4× 302 1.7× 63 0.6× 9 726
Guenter Daxenbichler Austria 7 261 0.8× 211 0.8× 152 0.8× 53 0.3× 44 0.4× 9 446
Kirsten Ritstier Netherlands 3 274 0.9× 164 0.6× 208 1.1× 124 0.7× 32 0.3× 3 426
Eva Colás Spain 15 392 1.2× 142 0.5× 321 1.7× 53 0.3× 180 1.6× 30 751

Countries citing papers authored by Colin R. James

Since Specialization
Citations

This map shows the geographic impact of Colin R. James's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin R. James with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin R. James more than expected).

Fields of papers citing papers by Colin R. James

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colin R. James. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin R. James. The network helps show where Colin R. James may publish in the future.

Co-authorship network of co-authors of Colin R. James

This figure shows the co-authorship network connecting the top 25 collaborators of Colin R. James. A scholar is included among the top collaborators of Colin R. James based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colin R. James. Colin R. James is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Buckley, Niamh E., et al.. (2016). Thromboxane A2 receptor (TBXA2R) is a potent survival factor for triple negative breast cancers (TNBCs). Oncotarget. 7(34). 55458–55472. 20 indexed citations
2.
Krell, Jonathan, Colin R. James, Deep Shah, et al.. (2011). Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Relapsing Post-Adjuvant Trastuzumab: Pattern of Recurrence, Treatment and Outcome. Clinical Breast Cancer. 11(3). 153–160. 16 indexed citations
3.
Palmieri, Carlo, Jonathan Krell, Colin R. James, et al.. (2010). Rechallenging with anthracyclines and taxanes in metastatic breast cancer. Nature Reviews Clinical Oncology. 7(10). 561–574. 52 indexed citations
4.
Quinn, Jennifer E., Judith Carser, Colin R. James, Richard D. Kennedy, & D. Paul Harkin. (2009). BRCA1 and implications for response to chemotherapy in ovarian cancer. Gynecologic Oncology. 113(1). 134–142. 67 indexed citations
5.
Gorski, Julia J., Colin R. James, Jennifer E. Quinn, et al.. (2009). BRCA1 transcriptionally regulates genes associated with the basal-like phenotype in breast cancer. Breast Cancer Research and Treatment. 122(3). 721–731. 64 indexed citations
6.
Quinn, Jennifer E., Colin R. James, Gail E. Stewart, et al.. (2007). BRCA1 mRNA Expression Levels Predict for Overall Survival in Ovarian Cancer after Chemotherapy. Clinical Cancer Research. 13(24). 7413–7420. 160 indexed citations
7.
James, Colin R., Jennifer E. Quinn, Paul B. Mullan, Patrick G. Johnston, & D. Paul Harkin. (2007). BRCA1, a Potential Predictive Biomarker in the Treatment of Breast Cancer. The Oncologist. 12(2). 142–150. 123 indexed citations
8.
Kennedy, Richard D., Julia J. Gorski, Jennifer E. Quinn, et al.. (2005). BRCA1 and c-Myc Associate to Transcriptionally Repress Psoriasin, a DNA Damage–Inducible Gene. Cancer Research. 65(22). 10265–10272. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026